| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/12/2004 | US20040157927 Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea |
| 08/12/2004 | US20040157925 Stable pharmaceutical composition of pravastatin |
| 08/12/2004 | US20040157909 Modulating protein kinase signal transduction; anticancer agents |
| 08/12/2004 | US20040157908 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/12/2004 | US20040157904 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 08/12/2004 | US20040157898 Antidiabetic agents; hypotensive agents; anticholesterol agents; antilipemic agents; antiinflammatory agents; antiproliferative agents |
| 08/12/2004 | US20040157895 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157890 Dyslipidemia; cardiovascular disorders; antidiabetic agents; eating disorders; antiinflammatory agents; anticholesterol agents |
| 08/12/2004 | US20040157889 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 08/12/2004 | US20040157888 Method of treating of demyelinating diseases or conditions |
| 08/12/2004 | US20040157886 Brain disorders; central nervous system disorders; viricides |
| 08/12/2004 | US20040157885 PPAR activators |
| 08/12/2004 | US20040157881 Function regulator for retinoid relative receptor |
| 08/12/2004 | US20040157875 1, 6-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/12/2004 | US20040157870 for treating or preventing attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder |
| 08/12/2004 | US20040157869 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |
| 08/12/2004 | US20040157866 Amide compounds |
| 08/12/2004 | US20040157857 Substituted chroman derivatives |
| 08/12/2004 | US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/12/2004 | US20040157838 pyrazolo[1,5-a]pyrimidine compounds; in particular CB1 receptor antagonists; antiobesity; antidepressant |
| 08/12/2004 | US20040157831 Therapeutic 5-HT ligand compounds |
| 08/12/2004 | US20040157828 Protease inhibitors |
| 08/12/2004 | US20040157812 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/12/2004 | US20040157799 Pharmaceutical uses of bisphosphonates |
| 08/12/2004 | US20040157785 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157302 exhibiting inhibitory activity against lanosterol synthase for preventive and therapeutic agents caused by accumulation of cholesterol in humans and antifungal agents; using streptomyces |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157259 Novel human ion channel protein and polynucleotides encoding the same |
| 08/12/2004 | US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156899 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 08/12/2004 | US20040156887 Stabilized dispersion of phytosterol in oil |
| 08/12/2004 | US20040156878 Implantable medical device seeded with mammalian cells and methods of treatment |
| 08/12/2004 | US20040156867 Proteosome influenza vaccine |
| 08/12/2004 | CA2514931A1 Oligosaccharide derivative |
| 08/12/2004 | CA2514612A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/12/2004 | CA2514575A1 Crystal of (23s)-1.alpha.-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same |
| 08/12/2004 | CA2514547A1 Receptor agonists |
| 08/12/2004 | CA2513753A1 Crystalline form of nateglinide |
| 08/12/2004 | CA2513641A1 Substituted heterocyclic compounds |
| 08/12/2004 | CA2511080A1 Fatigue reducing agent |
| 08/11/2004 | EP1445258A1 Activator for peroxisome proliferator-activated receptor delta |
| 08/11/2004 | EP1445256A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient |
| 08/11/2004 | EP1444978A1 Amino acid-containing tablets quickly disintegrating in the oral cavity and process for producing the same |
| 08/11/2004 | EP1444516A2 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 08/11/2004 | EP1444345A1 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 08/11/2004 | EP1444330A1 Expansion of t cells in vitro and expanded t cell populations |
| 08/11/2004 | EP1444328A2 Induction of beta cell differentiation in human cells |
| 08/11/2004 | EP1444265A2 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 08/11/2004 | EP1444233A2 A 2b? adenosine receptor antagonists |
| 08/11/2004 | EP1444232A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase |
| 08/11/2004 | EP1444228A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 08/11/2004 | EP1444227A1 Thiazolyl substituted triazoles as alk5 inhibitors |
| 08/11/2004 | EP1444226A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 08/11/2004 | EP1444224A2 3-substituted oxindole beta-3 agonists |
| 08/11/2004 | EP1444223A1 Aminopyrimidines and -pyridines |
| 08/11/2004 | EP1444219A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
| 08/11/2004 | EP1444215A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/11/2004 | EP1444212A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 08/11/2004 | EP1444204A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1444009A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443946A2 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 08/11/2004 | EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 08/11/2004 | EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443922A1 Mch antagonists for the treatment of obesity |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443898A2 Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells |
| 08/11/2004 | EP1399531A4 Methods and formulations for enhancing the dissolution of a solid material in liquid |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | EP1135381B1 Eletriptan hydrobromide monohydrate |
| 08/11/2004 | EP1109813B1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/11/2004 | EP1028732B1 Use of selected phytostenol esters for producing hypocholesteraemic preparations |
| 08/11/2004 | EP1003776B1 Screening method using FREAC-11 transcription factor |
| 08/11/2004 | EP0996508B1 Film coatings and film coating compositions based on dextrin |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | EP0805682B1 Dermatological use of vitamin d derivatives |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520422A Anti-obesity polypeptides |
| 08/11/2004 | CN1520414A Novel compound, its prepn. and application |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520404A Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520401A Calcilytic compounds |
| 08/11/2004 | CN1520301A Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520296A Amino nicotinate derivatives as glucokinase (GLK) modulators |
| 08/11/2004 | CN1520293A 3-flworo-pyrrolidines as antidiabetic agents |
| 08/11/2004 | CN1520290A Carbocyclic hydrorazino inhibitors of copper-containing amine oxidases |